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Abstract
Background: Primary open angle glaucoma (POAG) is considered to be a neurodegenerative
optic neuropathy, in which cell death occurs by apoptosis. p21, is an important protective
component of the apoptotic pathway, regulating cellular arrest in the presence of DNA damage.
An unstable or altered p21 protein could modify the cellular response to genomic injury and abolish
the effect of p21. A previous study on a Chinese cohort suggested that the p21 codon 31
polymorphism may alter the state of apoptosis in glaucomatous optic neuropathy, failing to protect
the ganglion cells. The aim of this study was to test the hypothesis that a p21 codon 31
polymorphism is associated with POAG on a Caucasian cohort.
Methods: 140 POAG patients and a control group of 73 healthy individuals were included in the
study. All the subjects were of Caucasian origin. Genomic DNA was amplified by polymerase chain
reaction, followed by enzymatic restriction fragment length polymorphism technique (PCR-RFLP).
Patients and controls were genotyped for a single nucleotide polymorphism (C/A transversion) in
the third base of codon 31 of p21, which leads to a serine (Ser)/arginine (Arg) substitution.
Results: The distribution of the genotypes in the POAG patients showed 128 (91.4%) Ser
homozygotes, 10 (7.1%) Ser/Arg heterozygotes and 2 (1.5%) Arg homozygotes. In the control
cohort, there were 61 (83.6%) Ser homozygotes and 12 (16.4%) Ser/Arg heterozygotes. No Arg
homozygotes were present amongst the control group. Both the allelic and genotypic frequencies
of the Ser or Arg residues at codon 31 were not significantly different between POAG patients and
controls (Fisher's exact test, P = 0.20 for alleles and P = 0.0561 for genotypes).
Conclusion: This study suggests that the p21 codon 31 polymorphism does not contribute to the
risk of POAG in the Caucasian population.
Background
Primary open angle glaucoma (POAG [MIM 137760]) is a
multifactorial neurodegenerative disease, causing blind-
ness to approximately 70 million individuals worldwide
[1,2]. The aetiology of POAG is poorly understood, with
both genetic and environmental factors contributing to
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factors leading to visual loss, most of which are still not
understood, the final common pathway in POAG is reti-
nal ganglion cell death, mediated by apoptosis, a geneti-
cally regulated process [5].
The apoptotic pathway consists of multiple interacting
pathways, some of which are still unclear. It appears that,
following DNA damage, cells can either proceed to apop-
tosis or enter a transient arrest cycle, allowing time for
DNA repair. p21 gene, also known as WAF1 or CIP1, is a
key component of this pathway. It can be up-regulated
either by activated wild type p53, which acts as a transcrip-
tion factor [6], or independently, by various factors such
as TGFβ, vitamin D, TPA and nerve growth factor. p21
expression results in inhibition of the cyclin-dependent
kinases (Cdks), that are essential for cell division. Conse-
quently, cell cycle is arrested at the G1 phase, until
genomic repair is established.
An unstable or altered p21 protein, therefore, could signif-
icantly affect the activity of Cdks, modifying the cellular
response to genomic injury and abolishing the protective
effect of p21. Such an outcome can derive from a single
nucleotide polymorphism in the third base of codon 31 of
the p21 gene, following a C to A transverse change, which
results in a Serine/Arginine amino acid substitution. This
polymorphism probably encodes a probable DNA-bind-
ing zinc-finger domain, causing functional changes to the
p21 protein.
There is evidence from a recent case-control study on a
Chinese cohort that the Arg allele of the p21 codon 31
polymorphism is more common amongst POAG patients
[7]. In this study, we tested the hypothesis of a possible
association between the p21 codon 31 polymorphism
and POAG on a Caucasian population.
Methods
Case selection
Having obtained ethical approval from our local research
ethics committee, blood samples were analysed from an
unrelated Caucasian cohort of 140 POAG patients and 73
controls from the north east of England.
The definition for POAG included characteristic cupping
of the optic disc, open iridocorneal angle and typical glau-
comatous visual field defects. An experienced glaucoma
specialist clinically examined both patients and control
groups (M.B.). Patients with intraocular pressure (IOP)
higher than 30 mmHg at first presentation and secondary
types of glaucoma (pseudoexfoliative, pigment dispersion
syndrome, trauma or steroid induced) were excluded. The
control group consisted of the spouses of our POAG
patients, who were free from any coexisting ocular pathol-
ogy and had normal visual acuity, IOP, visual fields and
optic discs.
Molecular genetic analysis
Purified genomic DNA was amplified by polymerase
chain reaction (PCR) for exon 2 of the p21 gene. For each
subject, 1 µl of DNA was mixed with 1 unit Taq DNA
polymerase (Promega, Madison, WI, USA), 10x Taq
polymerase buffer (Promega, Madison, WI, USA), 2 mmol
dNTP, 0.25 µM of each oligonucleotide (primer) and H2O
to total volume of 30 µl. The primers used were: Forward
(5'-GTC AGA ACC GGC TGG GGA TG -3') and reverse (5'-
CTC CTC CCA ACT CAT CCC GG -3'). Reactions were
treated in a thermal cycle machine to incubation at 94°C
for 5 min followed by 35 cycles of: 94°C for 30 sec,
57.2°C for 30 sec, 72°C for 30 sec and a final incubation
of 72°C for 7 min.
For each sample, the amplified PCR product was digested
with the restriction enzyme Blp I (New England Biolabs,
Beverly, Massachusetts, USA). The Blp I digestion mixture
contained 10 µl PCR product, 6 units of enzyme, 3 µl
buffer (NEB Buffer 4) and H2O to total volume of 20 µl.
The reactions were allowed to proceed for 12 hours at
37°C.
The resulting fragments were separated by electrophoresis
on a 3% agarose gel and visualised by ethidium bromide
staining with a digital camera. The Ser allele has a single
Blp I restriction site (GCTNAGC), resulting in two frag-
ments of 89 bp and 183 bp, where the Arg allele remains
undigested, producing a single band of 272 bp.
The molecular genetic analysis was performed in the same
laboratory by two investigators who were masked to the
phenotype of the samples studied.
Fisher's exact test was used to compare the genotype and
allele frequencies in cases and controls.
Results
Our cohort consisted of 140 POAG patients and 73 con-
trols. The median age was 73 years for the POAG patients
(range 51–87, S.D. = 8.01) and 78 years for the controls
(range 68–90, S.D. = 4.4). Mean IOP was 20.8 mmHg for
the patients (S.D. = 2.6) and 16.2 mmHg for the controls
(S.D. = 3.4). Median cup/disc ratio was 0.8 and 0.3 for
patients and controls respectively. The frequency distribu-
tion and the allelic frequencies of p21 codon 31 polymor-
phisms in POAG patients and healthy subjects are
illustrated in Table 1 and 2 respectively. The allele fre-
quencies follow Hardy-Weinberg proportions.
The distribution of the genotypes in the POAG patients
was 128 (91.4%) Ser homozygotes, 10 (7.1%) Ser/ArgPage 2 of 4
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trol cohort, there were 61 (83.6%) Ser homozygotes and
12 (16.4%) Ser/Arg heterozygotes. No Arg homozygotes
were present amongst the control group. We therefore
pooled the Arg/Arg groups with the Ser/Arg group for the
genotype analysis. Both the allelic and genotypic frequen-
cies of the Ser or Arg residues at codon 31 were not signif-
icantly different between POAG patients and controls
(Fisher's exact test, P = 0.20 for alleles and P = 0.0561 for
genotypes).
Discussion
Apoptosis and cell-cycle arrest are regulated through vari-
ous interacting pathways [8]. DNA damage leads to acti-
vation of transcription factors, such as the p53 gene, which
can induce apoptosis by up-regulating the protein Bax and
down-regulating the protein Bcl-2. Alternatively, DNA
insult can cause activation of the p21 gene, a tumour sup-
pressor gene, either directly or through transactivation by
wild type p53. p21 is a cyclin – dependent kinase inhibitor
resulting in cell-cycle arrest by inhibiting the G1 to S and
S to G2 phases [9]. Cancer research has revealed that
mutations of p21 are very rare and that single nucleotide
polymorphisms are more likely to have a functional effect
[10]. The Ser/Arg polymorphism at codon 31 is located in
a highly conserved region of the p21 [11] and has been
associated with cancer of the lungs, breast [12], bladder
[13], and colorectal tumours [14].
A recent study on a Chinese population showed an asso-
ciation between the Arg form of the p21 codon 31 poly-
morphism and POAG, suggesting that this allele may alter
the state of apoptosis in glaucomatous optic neuropathy,
failing to protect the ganglion cells [7].
In our cohort, we have not detected any statistically signif-
icant difference of the Ser and Arg allelic frequencies
between the POAG group and the healthy individuals.
This difference may reflect sampling bias, as the Chinese
cohorts were smaller (58 POAG patients and 59 control
subjects), or it could be attributed to ethnic disparity. The
Arg allele is considerably more common in Chinese, with
reported frequency of 0.50. Our findings correlate well
with previous studies on Swedish and French popula-
tions, which identified a low Arg allele frequency of 0.05
[15].
However, we cannot exclude the possibility of p21 codon
31 polymorphism being associated with POAG in other
ethnic groups or the likelihood of an association between
POAG and another p21 polymorphism. This might be a
worthwhile future strategy to elucidate the issue.
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Table 1: Frequency distribution of p21 codon 31 polymorphisms 
in POAG patients and healthy subjects. "Ser" and "Arg " 
represent encoding of Serine and Arginine, respectively, from 
the polymorphic site on exon 2.
Ser/Ser Ser/Arg Arg/Arg Total
POAG (n = 140) 128 (91.4%) 10 (7.1%) 2 (1.5%) 140
Controls (n = 73) 61 (83.6%) 12 (16.4%) 0 (0.0%) 73
Total 189 (88.8%) 22 (10.3%) 2 (0.9%) 213
Fisher's exact test: The two-tailed P value equals 0.0561. (Note: The 
frequencies of the Arg homozygotes were excluded from the analysis, 
as they were very low in the POAG group and 0 in the control group)
Table 2: Allelic frequencies in POAG patients and healthy 
subjects.
Ser Arg Total
POAG 266 (95%) 14 (5%) 280
Controls 134 (91.8%) 12 (8.2%) 146
Total 400 26 426
Fisher's exact test: The two-tailed P value equals 0.20.Page 3 of 4
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